Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 111 of the 156 sources its claims cite were checked for support.

Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review

Open access
Qin, Yulin, Wang, Jinxin, Lv, Quanzhen, Han, Bing · 2023 · Antimicrobial Agents and Chemotherapy

Abstract

Fungal infections, which commonly occur in immunocompromised patients, can cause high morbidity and mortality. Antifungal agents act by disrupting the cell membrane, inhibiting nucleic acid synthesis and function, or inhibiting β-1,3-glucan synthase.

Overview

CoChat Summary

TL;DR

This review summarizes antifungal agents that target mitochondrial components, especially electron transport chain complexes, DHODH, and Mir1, and catalogs their stages, spectra, MICs, in vivo efficacy, and selectivity. It concludes that mitochondria are promising but under-exploited antifungal targets, with only T-2307 and F90138 in clinical trials and most candidates still preclinical.

Key findings

  • T-2307 (phase II) inhibits mitochondrial respiratory chain CIII and CIV; reported MICs are 0.00025–0.0039 μg/mL against Candida, 0.125–4 μg/mL against Aspergillus, and 0.0039–0.06 μg/mL against Cryptococcus, with >1,000-fold selectivity.
  • F90138/olorofim (phase IIb) targets DHODH and is active against Aspergillus and Coccidioides with MIC ≤0.06 μg/mL; it shows >2,200-fold selectivity for A. fumigatus DHODH over the mammalian enzyme but is inactive against yeasts and Mucorales.
  • Preclinical candidates include ilicicolin H (cytochrome bc1/CIII; MICs 0.01–5.0 μg/mL for Candida, 0.1–1.56 μg/mL for Cryptococcus, 0.08 μg/mL for Aspergillus), ML316 (Mir1; Candida MIC 0.008–1.156 μg/mL; reduced oropharyngeal candidiasis burden 100-fold alone and >1,000-fold with fluconazole), and Inz-5 (CIII; C. albicans MIC50 0.15 μg/mL; 27.8-fold selectivity).
  • Natural products and antimicrobial peptides such as berberine, resveratrol, chiloscyphenol A, floricolin C, kalopanaxsaponin A, mefloquine derivatives, papaya seed extract, rosmarinic acid, P-113Du/P-113Tri, and ToAP2D affect mitochondrial function; many still lack specific targets, while P-113Du and P-113Tri inhibit NADH dehydrogenase/CI.

Methods

  • Narrative review; no primary experimental design. It synthesizes published studies on mitochondrion-targeted antifungal drugs and mitochondrial targets.
  • Data source: literature summarized in Table 1, covering agent, development stage, target, antifungal spectrum, in vitro MIC, in vivo efficacy, cytotoxicity IC50, and selectivity.
  • Main analysis: qualitative synthesis of mechanisms, selectivity, and development stage; no systematic review or meta-analysis is described.

Limitations

  • Stated: only a few drugs are under clinical trials; most agents target mitochondrial dysfunction broadly, and studies on other mitochondrial processes as targets are lacking. Exact targets of some compounds, such as 19ak and SM21, remain unclear, and some candidates have poor plasma or microsome stability.
  • Stated: the close evolutionary relationship between fungi and humans makes selective mitochondrial targeting challenging; clinical candidates do not act on fungus-specific proteins but are highly selective toward fungal cells.
  • Evident: as a narrative review, it lacks systematic search or inclusion criteria; many candidates are preclinical, and several Table 1 entries are “N/M,” limiting comparative efficacy and safety conclusions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/aac.00003-23

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIG 1 Chemical structures of antifungal agents recently explored that target mitochondria.
FIG 1 Chemical structures of antifungal agents recently explored that target mitochondria.CC BY · PubMed Central
FIG 2 Antifungal agents that target mitochondria and their mechanisms of actions. ATI-2307 acts by inhibiting CIII and CIV of ETC via the transportation of Agp2. F90138 (olorofim) blocks orotate synthesis from DHO by inhibiting the activity of DHODH. Ilicicolin H, Inz-1, and Inz-5 target CIII. ML316 is a novel and selective inhibitor of mitochondrial phosphate carrier protein (PiC) Mir1, which is a shuttle of inorganic phosphate from cytoplasm into mitochondrial matrix for ATP production. CI is also an important target of antifungal agents, for there are some Candida-specific proteins (Nuo1, Nuo2, and Goa1) in it. Deficiency of CI subunit proteins will cause CI disassembly and impaired fungal viability. 19ak and antimicrobial peptides P113, P-113Du, and P-113Tri are verified to target CI. Berberine, a natural product, accumulates inside fungal cytoplasm and causes damage of CI. Other compounds, natural products, and peptides, such as SM21, resveratrol, CA, and floricolin C, still lack specific antifungal targets. The antifungal agents are highlighted in red. Abbreviations: I to V, mitochondrial respiration complex I to V; ETC, electron transport chain; DHO, dihydroorotate; DHODH, dihydroorotate dehydrogenase; CA, chiloscyphenol A.
FIG 2 Antifungal agents that target mitochondria and their mechanisms of actions. ATI-2307 acts by inhibiting CIII and CIV of ETC via the transportation of Agp2. F90138 (olorofim) blocks orotate synthesis from DHO by inhibiting the activity of DHODH. Ilicicolin H, Inz-1, and Inz-5 target CIII. ML316 is a novel and selective inhibitor of mitochondrial phosphate carrier protein (PiC) Mir1, which is a shuttle of inorganic phosphate from cytoplasm into mitochondrial matrix for ATP production. CI is also an important target of antifungal agents, for there are some Candida-specific proteins (Nuo1, Nuo2, and Goa1) in it. Deficiency of CI subunit proteins will cause CI disassembly and impaired fungal viability. 19ak and antimicrobial peptides P113, P-113Du, and P-113Tri are verified to target CI. Berberine, a natural product, accumulates inside fungal cytoplasm and causes damage of CI. Other compounds, natural products, and peptides, such as SM21, resveratrol, CA, and floricolin C, still lack specific antifungal targets. The antifungal agents are highlighted in red. Abbreviations: I to V, mitochondrial respiration complex I to V; ETC, electron transport chain; DHO, dihydroorotate; DHODH, dihydroorotate dehydrogenase; CA, chiloscyphenol A.CC BY · PubMed Central

Verification

Claims the paper makes

97 Valid · 3 Not valid · 30 Not checked · 14 Own results and interpretations

64 more claims · 38 with their cited sources checked

Create a free account to see all 144 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 66
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 84 references

Cited by

See all 38

Metadata

Authors
Qin, Y., Wang, J., Lv, Q., & Han, B.
Affiliations
  • Fudan University (CN)
  • Second Military Medical University (CN)
Corresponding author
  • Lv, Quanzhen
  • Han, Bing
Venue
Antimicrobial Agents and Chemotherapy
Published
2023-06-15
Volume
67
Issue
6
Pages
e0000323-e0000323
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W4376873051
Cited by
38
References
84
Citations by year
2026: 14 · 2025: 13 · 2024: 11
FWCI
1.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • MOST | National Natural Science Foundation of China (82204468)
  • Shanghai Minhang District Health Commission (2021MW01)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
fungal infection, mitochondrial electron transport chain, mitochondrial respiration, reactive oxygen species, intracellular ATP, antifungal resistance, immunocompromised patients, lead compounds
MeSH terms
Antifungal Agents, Fungal Proteins, Humans, Mitochondria, Mycoses, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review. https://app.cochat.ai/papers/10.1128/aac.00003-23
The paper
Qin, Y., Wang, J., Lv, Q., & Han, B. (2023). Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00003-23

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.